Sasol (SSL) Q4 2026 Earnings Call Transcript

Sasol reported FY26 adjusted EBITDA of ZAR 61B (+17% YoY) driven by higher sales volumes, stronger oil prices and better fuel differentials, alongside net debt of USD 3.3B (11% lower YoY, lowest in 10 years). Capex fell 18% to ZAR 21B and free cash flow was ZAR 11.9B (5% lower YoY; +26% excluding a prior-year one-off legal settlement), while Secunda output hit 7.26M tonnes (five-year high). Management cut the Southern African oil breakeven to $49/bbl and guided FY27 capex of ZAR 23B–26B, while reiterating that dividends resume only when net debt is sustainably below USD 3B. International Chemicals delivered USD 604M adjusted EBITDA, though chemical oversupply and weaker demand remain risks, implying a cautious path for margins despite improved FY26 momentum.

Analysis

This is primarily a balance-sheet rerating setup, not a clean commodity-beta trade. The equity’s asymmetry improves as net debt approaches the dividend gate: if working capital normalizes and capex stays disciplined, incremental cash flow can translate into a faster-than-expected move from “deleveraging story” to “return-of-capital story.” That matters because the market usually pays a much higher multiple for a cyclical that can self-fund distributions than for one that merely prints peak EBITDA.

The second-order winner is the integrated South African value chain inside SSL: better coal quality and lower outside purchases reduce operating variance, which should lower the probability of another idiosyncratic production shock. The losers are external coal suppliers, import-dependent fuel traders, and commodity-sensitive chemical competitors facing a structurally tighter customer relationship model. The catch is that chemicals still look like the weakest leg; management is effectively saying FY27 upside is mostly self-help, so any margin slippage there would hit cash conversion quickly.

Contrarian view: the market may be overpricing the speed of dividend reinstatement and underpricing the cash drag from working capital, stronger rand exposure, and environmental/legal capex creep. The real falsifier is not a modest EBITDA miss; it is net debt failing to sustainably get through $3bn by FY27-28 or inventory staying elevated after the Q1 unwind. If Brent rolls over or ZAR strengthens materially, the equity could stall despite solid operations because the rerating thesis depends on cash, not just earnings.

Key Decisions for Investors

• Buy SSL on pullbacks over the next 2-6 weeks, with a 3-6 month target tied to confirmation of Q1 working-capital unwind; thesis works if net debt trends toward the sub-$3bn dividend threshold and fails if leverage plateaus above that zone.
• For higher-risk accounts, use SSL 6-12 month call spreads rather than outright stock to express the rerating toward dividend resumption; risk/reward is attractive if the market starts discounting capital returns before FY27 year-end.
• Set a trading alert on SSL if management revises FY27 working capital above ~17% of turnover or if Secunda shutdown execution slips; those are the fastest ways the cash-flow story can break.
• Avoid chasing the equity on headline EBITDA alone; if Brent weakens sharply or ZAR strengthens, take profits because the market will likely reprice the dividend timeline before it reprices the asset quality.
• Watch PRAX/Natref corporate action risk as a separate catalyst, but do not front-run it without valuation clarity; the upside is real only if any acquisition terms are immediately accretive to SSL FCF and leverage.